Squarepoint Ops 13F: Adds $15M to Albemarle (ALB) Stake
Squarepoint Ops expanded its holdings in Albemarle Corporation by 193.8% during the period.
Reviewed by automated data checks against the source filing. How we make and check alerts
Squarepoint Ops added 88,660 shares to its stake in Albemarle Corporation ($ALB), a 193.81% increase, according to a 13F filing with the SEC dated May 15, 2026. It reported 134,407 shares worth $22.59 million at the end of the quarter.
Since the filing, $ALB is down 4.9% after 1 week, down 6.1% after 1 month and down 46.8% to date (from the $179.32 close on May 15, 2026).
ALB
Albemarle Corporation
Key Points
- Squarepoint Ops grew its stake in Albemarle Corporation NYSE ALB by 193.8%, adding 88,660 shares to end the period with 134,407 shares valued at roughly $22.6 million.
- Albemarle shares trade near a spot price of $168.05, backed by a forward P/E ratio of 10.0 and a consensus buy rating from wall street firms.
- Wall street firms continue to evaluate the specialty chemicals maker, with recent updates coming from RBC Capital, Mizuho, and Barclays.
Get $ALB trade alerts by text
We text you when insiders, Congress or big funds trade $ALB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Albemarle Corporation alert may contain errors. Disclosures
Squarepoint Ops Expands Position in Albemarle Corporation
Squarepoint Ops boosted its holdings in Albemarle Corporation NYSE ALB by a wide margin, adding 88,660 shares during the period. According to a Form 13F filing with the SEC for the reporting period ending May 15, 2026, the fund lifted its total stake by 193.8% to reach 134,407 shares. That position carried a reported value of about $22.6 million based on transaction details.
Albemarle Stock Context and Recent Trading Levels
The shares recently traded at a spot price of $168.05 on Sunday. The company carries a forward P/E ratio of 10.0 alongside a trailing price-to-earnings measure of 418.2. Investors should keep in mind that 13F disclosures provide a backward-looking snapshot of holdings as of the end of the reporting period and may not represent current ownership today.
Recent Earnings Performance
For its most recent financial period, Albemarle reported revenue of $5.91 billion alongside revenue growth of 31.1%. The specialty chemicals firm posted earnings per share of $0.27, a net margin of 3.8%, and a return on equity of 2.6%. The company's next earnings report is scheduled for November 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
8 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 166.8%. Revenue beat estimates by 7.2%.
-
Profit surprise
EBITDA missed by 36 percent. Operating income beat by 41 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
8 target raises.
-
Earnings quality
Gross margin up 20.7 points. Operating margin up 14.7 points. Positive free cash flow.
Earnings Call Summary
Albemarle had a strong first quarter with $1.43 billion in revenue, up 33 percent from last year, and $664 million in adjusted earnings, more than double the prior year. The company benefited from higher lithium prices (up 51 percent), increased volumes in Energy Storage of 14 percent, and successful cost cutting that saved $40 million so far this year. The company paid down $1.3 billion of debt, improving its financial flexibility, and generated $248 million in free cash flow in the quarter.
Guidance Management raised their full year outlook for the Specialties business, now expecting between $1.3 billion and $1.5 billion in sales and $225 million to $275 million in adjusted earnings. They kept their Energy Storage outlook unchanged despite supply chain disruptions from the Middle East, estimating the cost impact at $70 million to $90 million. The company expects to offset these costs through lower interest expense from debt paydown and better than expected Specialties pricing and volumes.
Good report. The company beat and showed some forward improvement, with a few meaningful caveats.
Wall Street Analyst Views
Analyst firms have kept a close eye on the specialty chemical provider through recent months. On October 15, 2026, RBC Capital maintained an outperform rating while adjusting its price target to $129.00 from $157.00. Earlier, on October 14, 2026, Mizuho maintained an outperform rating with a $130.00 target. Barclays initiated coverage on October 13, 2026, with an equal-weight rating and a $109.00 target. Argus Research maintained a buy rating on October 7, 2026, setting a target of $135.00 down from $230.00. UBS maintained a buy rating on October 5, 2026, with a $150.00 target. Mizuho maintained a neutral rating at $130.00 on October 1, 2026, while JP Morgan kept a neutral rating at $140.00 on August 25, 2026. RBC Capital previously maintained an outperform rating with a $157.00 target on August 10, 2026. Overall, the stock holds a consensus buy recommendation across 20 analyst opinions with a mean price target of $171.56.
Inside the Specialty Chemicals Business
Headquartered in Charlotte, North Carolina, Albemarle Corporation provides energy storage solutions worldwide through its energy storage, specialties, and ketjen segments. The firm supplies lithium compounds for electric vehicle batteries, power grids, and consumer electronics, alongside bromine products and clean fuel technologies. Institutional maneuvers like the one reported by Squarepoint Ops offer visibility into how major managers position themselves across the basic materials sector.
What to Watch at Albemarle Corporation
Market participants will track upcoming regulatory filings and the company's earnings release in November to gauge how institutional portfolios evolve. Because 13F reports lag actual trading dates, investors typically look toward newer disclosures and corporate updates to track shifting sentiment.
Related Filing Alerts
Source: Squarepoint Ops's 13F filing on $ALB (May 15, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Squarepoint Ops 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts